StockTipsArenaBeta

BUY GlaxoSmithKline Pharmaceuticals Limited — IDBI Capital

BUYGlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))21 Jul 2026via IDBI Capital Research Calls Telegram

Entry₹2,502Stated
Target₹2,700
Total upside +7.91% (call closed)
Stop loss₹2,411-3.64% risk
At expiry₹2,664.93 Aug 2026, 3:30 pm
Expired+6.51%
Follow IDBI Capital for new calls(25% target hit, 375 closed calls)Get alertsWatch GLAXO for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 3 Aug 2026
3 supporting0 opposing
Supports the BUY call (3)

Nestle, GSK Pharma Show Momentum as Market Faces Pressure

NewsGoogle News·23 Jul · 2w ago

(opens in new tab)

Nestle, GSK Pharma में तेजी के संकेत, गिरावट में बाजार

NewsGoogle News·23 Jul · 2w ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·23 Jul · 2w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on GlaxoSmithKline Pharmaceuticals

All analyst calls on GlaxoSmithKline Pharmaceuticals

More from IDBI Capital

Every call and its outcome